Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.

Alzheimer's research & therapy - 2 Jan 2024

Waterink Lisa, Masselink Larissa A, van der Lee Sven J, Visser Leonie N C, Cleutjens Solange, van der Schaar Jetske, van Harten Argonde C, Scheltens Philip, Sikkes Sietske A M, van der Flier Wiesje M, Zwan Marissa D

Abstract excerpt

BACKGROUND: Apolipoprotein-E (APOE) genetic testing for Alzheimer's disease is becoming more important as clinical trials are increasingly targeting individuals carrying APOE-ε4 alleles. Little is known about the interest in finding out one's genetic risk for Alzheimer's disease in the general population. Our objective was to examine this in a sample of cognitively normal (CN) adults within a population-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Apolipoprotein E4

Share to Apolipoproteins E

Share to Disclosure

Share to Genetic Predisposition to Disease

Share to Genotype

Source

Open in PubMed Open full text

Identifiers

PMID: 38167083
DOI: 10.1186/s13195-023-01364-w
PMCID: PMC10759504

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.PMID 38167083Read ↗

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: A survey studySemantic proximity Read ↗

To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk.Semantic proximity Read ↗

Public perceptions of presymptomatic testing for Alzheimer disease.Semantic proximity Read ↗

Disclosure of APOE genotype for risk of Alzheimer's disease.Semantic proximity Read ↗

Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.Semantic proximity Read ↗

Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.Semantic proximity Read ↗

Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1.Semantic proximity Read ↗

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.Semantic proximity Read ↗

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Semantic proximity Read ↗

Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.Semantic proximity Read ↗

Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.Semantic proximity Read ↗

Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.